Probucol

Probucol

SCHEMBL4620631

CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1.N

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCA1

The experimentally established mechanism targets of Probucol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.95
HPN P05981 1/20 0.95
MAPT P10636 1/20 0.95
SIRT5 Q9NXA8 1/20 0.95
VCAM1 P19320 13/20 0.58
CA2 P00918 4/20 0.56
CA1 P00915 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 1/20 0.54
POLB P06746 1/20 0.54
TYR P14679 1/20 0.54
MEN1 O00255 1/20 0.44
GALR3 O60755 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Probucol SCHEMBL4150 0.98 HPN (1.00) ALOX15HPNMAPTSIRT5VCAM1
Probucol SCHEMBL5143451 0.98 HPN (1.00) ALOX15HPNMAPTSIRT5VCAM1
Probucol SCHEMBL8344652 0.95 ALOX15 (0.95) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL12791592 0.90 ALOX15 (0.84) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL4985953 0.90 HPN (0.84) ALOX15HPNMAPTSIRT5VCAM1
Probucol SCHEMBL8344272 0.88 HPN (0.81) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL4996488 0.88 ALOX15 (0.81) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL9506457 0.86 HPN (0.79) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL4983541 0.86 ALOX15 (0.78) ALOX15HPNMAPTSIRT5VCAM1
SCHEMBL15344011 0.85 ALOX15 (0.75) ALOX15HPNMAPTSIRT5VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851195-A4 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES CAMBREX CHARLES CITY INC (US) 2008-04-02 EP disclosed
US-7345191-B2 Process for preparation of probucol derivatives CAMBREX CHARLES CITY, INC. (US) 2008-03-18 US disclosed
US-7294736-B2 Process for preparation of probucol derivatives CAMBREX CHARLES CITY, INC. (US) 2007-11-13 US disclosed
EP-1851195-A1 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES Cambrex Charles City, Inc. (US) 2007-11-07 EP disclosed
EP-1756033-A4 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES CAMBREX CHARLES CITY INC (US) 2007-05-30 EP disclosed
EP-1756033-A1 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES Cambrex Charles City, Inc. (US) 2007-02-28 EP disclosed
WO-2006093501-A1 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES CAMBREX CHARLES CITY, INC. (US) 2006-09-08 WO disclosed
US-20060194875-A1 Process for preparation of probucol derivatives CAMBREX CHARLES CITY, INC. 2006-08-31 US disclosed
US-20060025481-A1 Process for preparation of probucol derivatives and polymorphic forms thereof STRANGE MATTHEW L 2006-02-02 US disclosed
WO-2005102985-A1 PROCESS FOR PREPARATION OF PROBUCOL DERIVATIVES CAMBREX CHARLES CITY, INC. (US) 2005-11-03 WO disclosed
US-20050228192-A1 Process for preparation of probucol derivatives CAMBREX CHARLES CITY, INC. 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025481-A1 Process for preparation of probucol derivatives and polymorphic forms thereof ADH1C, ADH5, CEL ALOX15 438/4885HPN 296/4885MAPT 3166/4885
US-20060194875-A1 Process for preparation of probucol derivatives APOB, NPC1L1, APOL1 ALOX15 760/4885HPN 1108/4885MAPT 3600/4885
US-20050228192-A1 Process for preparation of probucol derivatives APOB, NPC1L1, APOL1 ALOX15 760/4885HPN 1108/4885MAPT 3600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.